Flow-Controlled vs. Pressure-Controlled Ventilation in CABG: Effects on Lung Aeration and Diaphragm Function (FCV-PCV-DTI-LU)
Comparison of Flow-Controlled Ventilation and Pressure-Controlled Ventilation on Lung Aeration and Diaphragm Function in Patients Undergoing Elective Isolated On-Pump Coronary Artery Bypass Graft Surgery: A Single-Centre Prospective Randomised Controlled Trial
Studie Overzicht
Toestand
Toestand
Conditie
Conditie
Interventie / Behandeling
Interventie / Behandeling
Gedetailleerde beschrijving
Studietype
Studietype
Inschrijving (Geschat)
Inschrijving
Fase
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
Studiecontact
- Naam: Ebru GIRGIN DINC, M.D., DESAIC
- Telefoonnummer: 905446948852
- E-mail: grgnebru@gmail.com
Studie Locaties
-
-
Kartal
-
Istanbul, Kartal, Turkije (Türkiye), 34862
- Kosuyolu Heart Training and Research Hospital
-
-
Deelname Criteria
Geschiktheidscriteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Age ≥18 years
- Planned elective isolated on-pump coronary artery bypass graft (CABG) surgery
- ASA Physical Status Classification II-IV
- Written informed consent obtained
- Technically adequate acoustic window for lung and diaphragm ultrasonography
Exclusion Criteria:
- Emergency surgery
- Combined surgical procedures (e.g., valve repair/replacement + CABG)
- Preoperative requirement for invasive or non-invasive mechanical ventilation
- Known diaphragm paralysis or neuromuscular disease
- Severe COPD exacerbation or active pneumonia at time of surgery
- Body mass index ≥40 kg/m²
- Inability to obtain standard lung or diaphragm ultrasound images due to pleural effusion, thoracic deformity, or prior thoracic surgery
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Verdrievoudigen
Aantal wapens
Wapens en interventies
Deelnemersgroep / ArmDeelnemersgroep / Arm |
Interventie / BehandelingInterventie / Behandeling |
|---|---|
|
Experimenteel: FCV (Flow-Controlled Ventilation)
Intraoperative ventilation with a Flow-Controlled Ventilation device.
Target tidal volume: 6-8 mL/kg ideal body weight (IBW).
PEEP and peak airway pressure titrated to maximise dynamic compliance.
Respiratory rate adjusted to maintain EtCO₂ 35-45 mmHg.
FiO₂ targeted to SpO₂ ≥94%.
|
PCV is delivered using a standard anaesthesia workstation in pressure-controlled mode.
Inspiratory pressure is set to achieve a tidal volume of 6-8 mL/kg ideal body weight.
PEEP is titrated using the same compliance-guided algorithm applied in the FCV arm.
Unlike FCV, the inspiratory flow profile is decelerating and PEEP and peak airway pressure are not independently optimised in a compliance-guided manner within the same ventilation mode
|
|
Actieve vergelijker: PCV (Pressure-Controlled Ventilation)
Intraoperative pressure-controlled ventilation.
Inspiratory pressure adjusted to deliver a tidal volume of 6-8 mL/kg IBW.
PEEP titrated to maximise dynamic compliance, using the same algorithm as the FCV group.
Respiratory rate adjusted to maintain EtCO₂ 35-45 mmHg.
FiO₂ targeted to SpO₂ ≥94%.
|
FCV delivers tidal ventilation via a continuous triangular flow waveform, maintaining constant inspiratory and expiratory flow rates throughout the entire respiratory cycle.
PEEP and peak airway pressure are titrated independently, guided by dynamic respiratory system compliance.
Tidal volume target is 6-8 mL/kg ideal body weight.
This ventilation modality is distinct from pressure-controlled and volume-controlled modes, which generate decelerating inspiratory flow profiles and do not allow simultaneous independent titration of PEEP and peak airway pressure based on compliance.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Total Lung Ultrasound Score (LUS)
Tijdsspanne: Preoperatively (T0), within 30 minutes of sternal closure while intubated (T1), and 24 hours postoperatively after extubation (T2)
|
Lung aeration assessed using a 12-zone bilateral ultrasonography protocol.
Each zone scored 0-3 (0 = normal aeration with A-lines; 1 = multiple B-lines; 2 = coalescent B-lines; 3 = consolidation).
Total score ranges from 0 to 36; higher scores indicate greater aeration loss
|
Preoperatively (T0), within 30 minutes of sternal closure while intubated (T1), and 24 hours postoperatively after extubation (T2)
|
Secundaire uitkomstmaten
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Diaphragm Thickening Fraction (TFdi)
Tijdsspanne: Preoperatively (T0), within 30 minutes of sternal closure while intubated (T1), and 24 hours postoperatively after extubation (T2)
|
Bilateral diaphragm thickening fraction measured via B-mode and M-mode ultrasonography at the zone of apposition using a linear probe (7-12 MHz).
TFdi (%) = [(T_insp - T_exp) / T_exp] × 100.
|
Preoperatively (T0), within 30 minutes of sternal closure while intubated (T1), and 24 hours postoperatively after extubation (T2)
|
|
Diaphragm Excursion
Tijdsspanne: Preoperatively (T0), within 30 minutes of sternal closure while intubated (T1), and 24 hours postoperatively after extubation (T2)
|
Bilateral inspiratory diaphragm dome displacement measured via M-mode ultrasonography using a convex probe (2-5 MHz) via subcostal approach.
|
Preoperatively (T0), within 30 minutes of sternal closure while intubated (T1), and 24 hours postoperatively after extubation (T2)
|
|
PaO₂/FiO₂ Ratio
Tijdsspanne: Preoperatively (T0), within 30 minutes of sternal closure while intubated (T1), and 24 hours postoperatively after extubation (T2)
|
Ratio of arterial oxygen partial pressure to fractional inspired oxygen, calculated from arterial blood gas analysis.
|
Preoperatively (T0), within 30 minutes of sternal closure while intubated (T1), and 24 hours postoperatively after extubation (T2)
|
|
Postoperative Pulmonary Complications
Tijdsspanne: Up to 30 days postoperatively
|
Composite of clinically significant pulmonary complications including radiologically confirmed atelectasis, pneumonia, and re-intubation, assessed according to pre-specified definitions.
|
Up to 30 days postoperatively
|
Medewerkers en onderzoekers
Sponsor
Sponsor
Onderzoekers
Onderzoekers
- Hoofdonderzoeker: Ebru GIRGIN DINC, Koşuyolu Kartal Heart Training and Research Hospital
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Studie start
Primaire voltooiing (Geschat)
Primaire voltooiing
Studie voltooiing (Geschat)
Studie voltooiing
Studieregistratiedata
Eerst ingediend
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Eerst geplaatst
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update geplaatst
Laatste update ingediend die voldeed aan QC-criteria
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
Andere studie-ID-nummers
- FCV-PCV-DTI-LUS
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .